EDITORIAL SECTION

Articles

Revolutionizing Biomanufacturing: Single-use Systems at the Forefront

In the rapidly evolving field of biomanufacturing singleuse systems have emerged as a gamechanger With their ability to optimize efficiency reduce contamination risks and lower costs these systems are revolutionizing the way biopharmaceuticals are produced

Partnership & Collaboration: The Strategic Force Shaping the Future of Pharmaceutical Growth

The pharmaceutical industry is being reshaped by a simple but powerful reality no company however large or capable can build every capability alone The sector is operating in an environment defined

Combination Immunotherapy Trials: Designing the Next Generation of Cancer Drugs

For most of the past ten years the prevailing strategy in immunooncology was addition Checkpoint blockade delivered durable remissions in a minority of patients the intuitive fix was to attach a second agent to a PD or PDL backbone and watch whether response rates moved

The Rise of Bioprinting: Opportunities and Challenges for Personalized Sterile Dosage Forms

Personalized medicine also known as precision medicine has gained significant traction in recent years transforming the healthcare landscape By considering an individuals unique genetic molecular and environmental factors personalized medicine aims to provide targeted therapies that maximize treatment effectiveness while minimizing adverse effects This approach

Ethical Sourcing in Pharma: Top Strategies for Sustainable Supply Chains in 2026

Pharmaceutical business is moving into a decisive decade in which ethical sourcing has ceased being a corporate value of goodwill and has become a strategic need Pharma ethical sourcing is closely connected to business continuity regulatory compliance environmental stewardship and brand trust in With supply chains that are increasingly global fragmented and vulnerable to geopolitical climatic and...

Reshaping Biologics Production Integrating Human Intelligence, AI, and Digital Twins for a Resilient Biologics Future

Biological medicines are not manufactured They are cultivated Every monoclonal antibody plasmaderived immunoglobulin and biosimilar molecule begins its journey inside a living cell That origin creates a category of operational challenge with no equivalent in smallmolecule production the product is the process Variations in temperature pH dissolved oxygen or nutrient concentration do not merely aff...

Techno Trends

Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein

Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue

Projects

SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing

SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more

Research Insights

A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG

PIGACDG is a congenital disorder of glycosylation caused by pathogenic partial lossoffunction variants in the PIGA gene PIGA encodes an enzyme responsible for the catalytic transfer of Nacetylglucosamine

whitepaper

Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact

For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys